Comparison of PET/CT using 68Ga-NOTA-Exendin-4 with 68Ga-DOTATATE, 18F-FDG, and conventional imaging in the localization of insulinomas
European Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.1007/s00259-025-07288-x ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Haonan Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of PET/CT Diagnostic, Tianjin Medical University General Hospital, Tianjin, 300052, China. Hauptthemen laut MEDLINE: Exenatide, Fluorodeoxyglucose F18, Insulinoma, Organometallic Compounds. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Joint Funds for the Innovation of Science and Technology, Fujian Province.
Abstract (Originalsprache)
PURPOSE: Accurate preoperative localization is particularly important for surgical treatment of insulinomas. Current imaging methods, including 18F-FDG (FDG) PET/CT, 68Ga-DOTATATE (TATE) PET/CT, CE-CT, and CE-MRI, have limitations. This prospective study provides a direct comparison of 68Ga-NOTA-Exendin-4 (Ex4) PET/CT with other imaging techniques. METHOD: 47 patients with biochemically proven endogenous hyperinsulinemic hypoglycemia underwent Ex4 PET/CT and other imaging methods. Sensitivity and accuracy of all imaging procedures for localizing insulinoma were calculated at the patient level and lesion level. Both clinical (>10 years experience) and junior (< 2 years experience) nuclear medicine physician readings were used to assess the diagnostic efficacy. We compared the SUVmax and tumor-to-background ratio (TBR) of three tracers and analyzed the values with Ki-67, maximum tumor diameter, and glucose metabolism indicators. RESULTS: In patient level, the sensitivity and accuracy of Ex4 PET/CT (94.11% and 95.74%) were higher than TATE PET/CT (70.59%, p = 0.026; 78.72%, p = 0.030), FDG PET/CT (50.00%, p < 0.001; 63.83%, p < 0.001), CE-CT (77.77%, p = 0.135; 72.22%, p = 0.007), and CE-MRI (63.64%, p = 0.135; 43.75%, p < 0.001), respectively. Interobserver agreement was higher for Ex4 PET/CT than TATE PET/CT and FDG PET/CT (Cohen κ, 0.839 vs. 0.707 and 0.784, respectively). SUVmax and TBR of Ex4 and TATE PET/CT were significantly higher than FDG PET/CT (p < 0.01). Negative correlations of tumor Ki-67 with TATE PET/CT were observed with SUVmax (r = -0.637, p < 0.001). SUVmax and TBR of three molecular imaging methods had positive correlations with the maximum tumor diameter (p < 0.05), except TBR of FDG PET/CT. Semi-quantitative values of the three tracers showed no correlation with the lowest blood glucose level, corresponding insulin, and C-peptide level. TBR of TATE PET/CT showed a positive correlation with C-peptide (r = 0.393, p = 0.043). CONCLUSION: Ex4 PET/CT showed superior characteristics in localization compared to routine imaging modalities in benign insulinomas. Ex4 PET/CT demonstrates better imaging quality and interpretability than FDG PET/CT and TATE PET/CT. Combined Ex4 and TATE PET/CT could provide a comprehensive evaluation/localization of insulinoma. TRIAL REGISTRATION: The trial was retrospectively registered at ClinitalTrial.gov (NCT06690957 and NCT06725693) on November 14, 2024 and December 5, 2024.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of PET/CT Diagnostic, Tianjin Medical University General Hospital, Tianjin, 300052, China.
- The Clinical Research and Translational Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian Province, China.
- Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, 300052, China.
- Department of Radiology, Tianjin Medical University General Hospital, Tianjin, 300052, China. dr_lidong@163.com.
- Department of PET/CT Diagnostic, Tianjin Medical University General Hospital, Tianjin, 300052, China. qs_c8@hotmail.com.
- Department of PET/CT Diagnostic, Tianjin Medical University General Hospital, Tianjin, 300052, China. yaoshaobo008@163.com.
ORCID-Profile: Shaobo Yao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Joint Funds for the Innovation of Science and Technology, Fujian Province
Zitieren
APA
Yu, H., Bao, X., Gu, Y., Pan, M., He, Q., Li, D., Chen, Q., & Yao, S. (2025). Comparison of PET/CT using 68Ga-NOTA-Exendin-4 with 68Ga-DOTATATE, 18F-FDG, and conventional imaging in the localization of insulinomas. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07288-x
Vancouver
Yu H, Bao X, Gu Y, Pan M, He Q, Li D, et al. Comparison of PET/CT using 68Ga-NOTA-Exendin-4 with 68Ga-DOTATATE, 18F-FDG, and conventional imaging in the localization of insulinomas. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07288-x
BibTeX
@article{Yu2025,
author = {Yu, Haonan and Bao, Xiangyuan and Gu, Yian and Pan, Meijie and He, Qing and Li, Dong and Chen, Qiusong and Yao, Shaobo},
title = {Comparison of PET/CT using 68Ga-NOTA-Exendin-4 with 68Ga-DOTATATE, 18F-FDG, and conventional imaging in the localization of insulinomas},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.1007/s00259-025-07288-x}
}
EUVIMED